News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Drug as First OTC Morning After Pill, Lifts Age Limit



6/21/2013 8:41:15 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

The U.S. Food and Drug Administration on Thursday expanded its approval of the so-called "morning after" contraceptive pill to include all women of child-bearing age to comply with an order from a U.S. District court. The FDA said the Plan B One-Step emergency contraceptive, which is sold by Teva Pharmaceutical Industries, would be made available as an over-the-counter (OTC) product without age or point-of-sale restrictions. Plan B One-Step is a single dose pill intended to reduce the chance of pregnancy following unprotected sex or suspected contraceptive failure, such as a broken condom.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES